A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

Summary

This study is a multi-center, double-blinded, randomized, study of bardoxolone methyl treatment in patients with End-Stage Renal Disease (ERSD) and Type 2 Diabetes Mellitus (T2DM) on peritoneal dialysis.

Timeline

Start

2012-07-31

Primary completion

2012-10-31

Completion

2012-10-31

Outcome

Outcome not reported

Stopped: “IDMC recommendation for safety concerns”

Drugs

Indications